Changes in fees for conducting pharmacovigilance activities



The European Commission has adopted a Delegated Regulation amending Regulation (EU) No 658/2014 of the European Parliament and of the Council as regards the adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use.

Regulation (EU) No 658/2014 of the European Parliament and of the Council of 15 May 2014 on fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use Text with EEA relevance - Article - Article 15(6) - For more information Click here

SOURCE: webgate.ec.europa.eu


                   

Related News